Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06397937 · ClinicalTrials.gov registry record · NA

SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes

A NA study of Stroke and Social Determinants of Health, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
275
Enrollment target
1
Study location

NCT06397937 is a NA study of Stroke and Social Determinants of Health that is actively recruiting participants, run by Columbia University. The registered enrollment target is 275 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06397937, a NA study of Stroke and Social Determinants of Health, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
275 participants
Enrollment target
1
Study location

Study Summary

Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and telomere length, at 6 months and 1-year post-stroke, compared with usual care (UC).

Interventions

  • BEHAVIORAL SHIFT team intervention

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 275 participants
Start Date 2024-09-15
Est. Completion 2029-01-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06397937

The ClinicalTrials.gov registry entry for NCT06397937 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which SHIFT team intervention is the first listed.

NCT06397937 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06397937 about?

NCT06397937 is a clinical study titled "SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes". Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3...

What is the current status of trial NCT06397937?

This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2024-09-15. Estimated completion is 2029-01-31.

What conditions does trial NCT06397937 study?

This clinical trial studies the following conditions: Stroke, Social Determinants of Health.

What interventions are being tested in trial NCT06397937?

The interventions under investigation include: SHIFT team intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06397937?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06397937 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.